It’s Time for an Actos Recall in the U.S., Says Attorney Michael J. Evans

“Big money and bad drugs are a dangerous combination,” says Attorney Michael J. Evans, owner of The Law Offices of Michael J. Evans, LLC,, says it’s time for an Actos recall in the United States. Evans posted the argument

in favor of an Actos recall on his website, Michael J. Evans, Law + Marketing + Technology,

Actos Recall Social Media Campaign

To try to build public support for an Actos recall, Evans has started a social media campaign to educate people about the risks of Actos and build support for an Actos Recall. The Actos social media campaign includes the following:

“France and Germany recalled Actos in June 2011 because studies showed the drug increased patients’ risks of bladder cancer and congestive heart failure. But in the U.S.,” Evans said, “the FDA merely issued a warning.

Evans says events of the past three months show that an Actos recall is needed now more than ever. Evans pointed to the following developments as proof that an Actos recall necessary:

[Continue reading…]

Actos Bladder Cancer Link Alleged in Lawsuit

If the diabetes does not kill you, the bladder cancer might. That’s the gist of a lawsuit, filed April 25 in the Louisiana Western District Court, in which plaintiff Donald Shingleton alleges he suffers from bladder cancer after taking Actos for se

veral years.

Actos is a drug used to control type 2 diabetes. It has been a blockbuster for its maker, Japan-based Takeda which last year logged $4.5 billion in Actos sales.

Diabetes is an ever more common disease in the United States. The American Diabetes Association estimates that nearly 26 million of us – almost 10 percent of the population – suffers from diabetes, a disease characterized by the body’s inability to manufacture or to efficiently use insulin. It is linked to cardiovascular disease, kidney failure and blindness. [Continue reading…]